Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-11 to 2023-05-12
Current total value of award: $1410.68
Description: 4560951540!HYDROXYZINE 50 MG/ML VIALML